Avalo Therapeutics Disclosed Cash Of Approximately $6.3M As Of June 30, 2023
Portfolio Pulse from Benzinga Newsdesk
Avalo Therapeutics has disclosed that it had approximately $6.3 million in cash as of June 30, 2023.
August 04, 2023 | 1:03 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Avalo Therapeutics has disclosed its cash position of approximately $6.3 million as of June 30, 2023.
The disclosure of Avalo Therapeutics' cash position provides transparency to investors, but it does not necessarily indicate a positive or negative impact on the company's stock price in the short term. The impact would depend on whether the cash position meets, exceeds, or falls short of market expectations, which is not specified in the news.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100